Human cytochrome p450 2A13 efficiently metabolizes chemicals in air pollutants: Naphthalene, styrene, and toluene

被引:58
作者
Fukami, Tatsuki [1 ]
Katoh, Miki [1 ]
Yamazaki, Hiroshi [1 ]
Yokoi, Tsuyoshi [1 ]
Nakajima, Miki [1 ]
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan
关键词
D O I
10.1021/tx700325f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Human P450 2A13 is the most efficient enzyme for catalyzing the metabolism of nicotine and metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). It is conceivable that P450 2A13 also metabolizes chemicals in air pollutants because this enzyme is highly expressed in the respiratory tract. In this study, we investigated the possibility that P450 2A13 can metabolize naphthalene, styrene, and toluene, which are included in air pollutants as well as tobacco smoke, although they were known to be metabolized by P450 1A2 or 2E1. We found that P450 2A13 catalyzed 1- and 2-naphthol formations from naphthalene with higher intrinsic clearances (kcat/Km) (3.1- and 2.2-fold, respectively) than P450 1A2 and also more efficiently catalyzed the styrene 7,8-oxide formation from styrene and the benzylalcohol formation from toluene than P450 2E1. The overlapping substrate specificity of P450 2A13 with P450 2E1 was supported by the finding that P450 2A13 catalyzed chlorzoxazone 6-hydroxylation (8-fold higher value of kcat/Km) and p-nitrophenol 2-hydroxylation (19-fold higher value of kcat/Km), which are marker activities of P450 2E1. Thus, we found that P450 2A13 metabolizes diverse environmental chemicals and has overlapping substrate specificities of P450 1A2 and 2E1, suggesting that P450 2A13 plays important roles in the local metabolism of environmental chemicals in the respiratory tract related to toxicity or carcinogenicity.
引用
收藏
页码:720 / 725
页数:6
相关论文
共 48 条
[41]   Characterisation of the toxic metabolite(s) of naphthalene [J].
Wilson, AS ;
Davis, CD ;
Williams, DP ;
Buckpitt, AR ;
Pirmohamed, M ;
Park, BK .
TOXICOLOGY, 1996, 114 (03) :233-242
[42]   CYP2A6 and CYP2B6 are involved in nornicotine formation from nicotine in humans: Interindividual differences in these contributions [J].
Yamanaka, H ;
Nakajima, M ;
Fukami, T ;
Sakai, H ;
Nakamura, A ;
Katoh, M ;
Takamiya, M ;
Aoki, Y ;
Yokoi, T .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (12) :1811-1818
[43]   THE CYP2A3-GENE PRODUCT CATALYZES COUMARIN 7-HYDROXYLATION IN HUMAN LIVER-MICROSOMES [J].
YAMANO, S ;
TATSUNO, J ;
GONZALEZ, FJ .
BIOCHEMISTRY, 1990, 29 (05) :1322-1329
[44]   Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli [J].
Yamazaki, H ;
Nakamura, M ;
Komatsu, T ;
Ohyama, K ;
Hatanaka, N ;
Asahi, S ;
Shimada, N ;
Guengerich, FP ;
Shimada, T ;
Nakajima, M ;
Yokoi, T .
PROTEIN EXPRESSION AND PURIFICATION, 2002, 24 (03) :329-337
[45]  
YASUKOCHI Y, 1976, J BIOL CHEM, V251, P5337
[46]   Development of a real-time polymerase chain reaction-based method for the measurement of relative allelic expression and identification of CYP2A13 alleles with decreased expression in human lung [J].
Zhang, XL ;
Caggana, M ;
Cutler, TL ;
Ding, XX .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01) :373-381
[47]   Genetic Polymorphisms of the human CYP2A13 gene: Identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant [J].
Zhang, XL ;
Su, T ;
Zhang, QY ;
Gu, J ;
Caggana, M ;
Li, HM ;
Ding, XX .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (02) :416-423
[48]   CYP2A13 in human respiratory tissues and lung cancers: An immunohistochemical study with a new peptide-specific antibody [J].
Zhu, Liang-Ru ;
Thomas, Paul E. ;
Lu, Gang ;
Reuhl, Kenneth R. ;
Yang, Guang-Yu ;
Wang, Li-Dong ;
Wang, Shou-Lin ;
Yang, Chung S. ;
He, Xiao-Yang ;
Hong, Jun-Yan .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (10) :1672-1676